Publication | Closed Access

Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant

VaccinationMucosal VaccinationEnterohaemorragic Escherichia ColiVaccine DevelopmentMicrobial PathogensVaccine TargetImmunologyImmunodominanceInfection ControlIntranasal VaccinationVaccine DesignMedicineTlr2/6 Agonist Malp-2